Literature DB >> 19838667

[Bone tissue engineering in clinical application : assessment of the current situation].

P Bernstein1, M Bornhäuser, K-P Günther, M Stiehler.   

Abstract

Treatment of severe bone defects remains a challenge in orthopaedic surgery and traumatology. Surgical techniques should provide primary stability to reach osseous integration and secondary remodeling of bone grafts and substitute materials. None of the currently available substitute materials provides osteoconduction and osteogenesis comparable to those of human allografts and autografts. To enhance osteoinductive and osteogenetic properties of these implants mesenchymal stem cells are used successfully in bone tissue engineering approaches. The aim of this report is to summarize the currently available data on bone tissue engineering and preliminary experience with a tissue engineered graft in acetabular revision surgery after loosening of a hip replacement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838667     DOI: 10.1007/s00132-009-1493-8

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  31 in total

1.  Validation of the sterilization procedure of allogeneic avital bone transplants using peracetic acid-ethanol.

Authors:  A Pruss; B Baumann; M Seibold; M Kao; K Tintelnot; R von Versen; H Radtke; T Dörner; G Pauli; U B Göbel
Journal:  Biologicals       Date:  2001-06       Impact factor: 1.856

2.  Rapid bone and blood flow formation in impacted morselized allografts: positron emission tomography (PET) studies on allografts in 5 femoral component revisions of total hip arthroplasty.

Authors:  Jens Sörensen; Gösta Ullmark; Bengt Långström; Olle Nilsson
Journal:  Acta Orthop Scand       Date:  2003-12

3.  Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.

Authors:  Wei Zhu; Wenrong Xu; Runqiu Jiang; Hui Qian; Miao Chen; Jiabo Hu; Weike Cao; Chongxu Han; Yongchang Chen
Journal:  Exp Mol Pathol       Date:  2005-10-07       Impact factor: 3.362

4.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

Review 5.  State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective.

Authors:  Dietmar Werner Hutmacher; Jan Thorsten Schantz; Christopher Xu Fu Lam; Kim Cheng Tan; Thiam Chye Lim
Journal:  J Tissue Eng Regen Med       Date:  2007 Jul-Aug       Impact factor: 3.963

Review 6.  Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate.

Authors:  G M Blake; S J Park-Holohan; G J Cook; I Fogelman
Journal:  Semin Nucl Med       Date:  2001-01       Impact factor: 4.446

7.  Acetabular and femoral reconstruction with impacted graft and cement.

Authors:  T J Slooff; P Buma; B W Schreurs; J W Schimmel; R Huiskes; J Gardeniers
Journal:  Clin Orthop Relat Res       Date:  1996-03       Impact factor: 4.176

8.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

9.  Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones.

Authors:  Hiroshi Kitoh; Takahiko Kitakoji; Hiroki Tsuchiya; Mitsuyasu Katoh; Naoki Ishiguro
Journal:  Bone       Date:  2006-10-27       Impact factor: 4.398

10.  Bone tissue engineering using novel interconnected porous hydroxyapatite ceramics combined with marrow mesenchymal cells: quantitative and three-dimensional image analysis.

Authors:  Masataka Nishikawa; Akira Myoui; Hajime Ohgushi; Masako Ikeuchi; Noriyuki Tamai; Hideki Yoshikawa
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

View more
  6 in total

Review 1.  [Bone substitute. Transplants and replacement materials--an update].

Authors:  C Rentsch; B Rentsch; D Scharnweber; H Zwipp; S Rammelt
Journal:  Unfallchirurg       Date:  2012-10       Impact factor: 1.000

Review 2.  Recommendations and considerations for the use of biologics in orthopedic surgery.

Authors:  Stefan Zwingenberger; Christophe Nich; Roberto D Valladares; Zhenyu Yao; Maik Stiehler; Stuart B Goodman
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

3.  Revision of Total Hip Arthroplasty with Acetabular Bone Defects: Are Biological Grafts Really Better than Synthetic Bone Graft Substitutes?

Authors:  Luca Costanzo Comba; Enrico Bellato; Danilo Colombero; Lorenzo Mattei; Antongiulio Marmotti; Filippo Castoldi
Journal:  Arch Bone Jt Surg       Date:  2022-07

Review 4.  [Biological downsizing : Acetabular defect reconstruction in revision total hip arthroplasty].

Authors:  S Koob; S Scheidt; T M Randau; M Gathen; M D Wimmer; D C Wirtz; S Gravius
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

5.  Quality Evaluation of Human Bone Marrow Mesenchymal Stem Cells for Cartilage Repair.

Authors:  Katsunori Shiraishi; Naosuke Kamei; Shunsuke Takeuchi; Shinobu Yanada; Hisashi Mera; Shigeyuki Wakitani; Nobuo Adachi; Mitsuo Ochi
Journal:  Stem Cells Int       Date:  2017-08-01       Impact factor: 5.443

Review 6.  Review of various treatment options and potential therapies for osteonecrosis of the femoral head.

Authors:  Huijuan Cao; Hanfeng Guan; Yuxiao Lai; Ling Qin; Xinluan Wang
Journal:  J Orthop Translat       Date:  2015-10-24       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.